Patents by Inventor Anil Jagtap

Anil Jagtap has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230040736
    Abstract: The present invention relates to novel organic dinitroxide biradical compounds and their use as polarizing agents, in particular, in the techniques of Nuclear Magnetic Resonance (NMR) of solids or liquid samples and medical imaging.
    Type: Application
    Filed: July 18, 2022
    Publication date: February 9, 2023
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, University of Iceland
    Inventors: Gaël De Paepe, Frédéric Mentink-Vigier, Snorri Sigurdsson, Anil Jagtap
  • Patent number: 11472790
    Abstract: The present invention relates to novel organic dinitroxide biradical compounds and their use as polarizing agents, in particular, in the techniques of Nuclear Magnetic Resonance (NMR) of solids or liquid samples and medical imaging.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: October 18, 2022
    Assignees: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, University of Iceland
    Inventors: Gaël De Paepe, Frédéric Mentink-Vigier, Snorri Sigurdsson, Anil Jagtap
  • Publication number: 20200148666
    Abstract: The present invention relates to novel organic dinitroxide biradical compounds and their use as polarizing agents, in particular, in the techniques of Nuclear Magnetic Resonance (NMR) of solids or liquid samples and medical imaging.
    Type: Application
    Filed: July 3, 2018
    Publication date: May 14, 2020
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, University of Iceland
    Inventors: Gaël De Paepe, Frédéric Mentink-Vigier, Snorri Sigurdsson, Anil Jagtap
  • Publication number: 20110245289
    Abstract: Imidazoquinolines of formula I that contain substituted amine or amide functionality at 1-position and that are effective as Toll like Receptor 7 activators are disclosed. These compounds are useful as anticancer agents.
    Type: Application
    Filed: March 23, 2009
    Publication date: October 6, 2011
    Applicant: 4SC AG
    Inventors: Volker Gekeler, Thomas Maier, Astrid Zimmermann, Hans-Peter Hofmann, Sanjeev Kulkarni, Anil Jagtap, Ganesh Chaure